- Home
- Publications
- Publication Search
- Publication Details
Title
Tumour budding and tumour–stroma ratio in hepatocellular carcinoma
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-04
DOI
10.1038/s41416-020-0847-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A classification based on tumor budding and immune score for patients with hepatocellular carcinoma
- (2019) Li Wei et al. OncoImmunology
- Tumor budding is a prognostic factor linked to epithelial mesenchymal transition in pancreatic ductal adenocarcinoma. Study report and literature review
- (2018) Ezzeddine Chouat et al. PANCREATOLOGY
- Tumour-stroma ratio and prognosis in gastric adenocarcinoma
- (2018) Niko Kemi et al. BRITISH JOURNAL OF CANCER
- Tumor Budding and Prognosis in Gastric Adenocarcinoma
- (2018) Niko Kemi et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016
- (2017) Alessandro Lugli et al. MODERN PATHOLOGY
- Tenascin-C and fibronectin in normal esophageal mucosa, Barrett’s esophagus, dysplasia and adenocarcinoma
- (2017) Joni Leppänen et al. Oncotarget
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
- (2017) et al. JAMA Oncology
- Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer
- (2016) A C Rogers et al. BRITISH JOURNAL OF CANCER
- Tumor Budding: The Name is EMT. Partial EMT.
- (2016) Alexandru Grigore et al. Journal of Clinical Medicine
- Tumor Budding Is an Independent Adverse Prognostic Factor in Pancreatic Ductal Adenocarcinoma
- (2015) Kate O’Connor et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Tumor–stroma ratio is a prognostic factor for survival in hepatocellular carcinoma patients after liver resection or transplantation
- (2015) Zhen Lv et al. SURGERY
- Tumour budding in head and neck squamous cell carcinoma - a systematic review
- (2014) Alhadi Almangush et al. HISTOPATHOLOGY
- Tumor–stroma ratio is an independent predictor for survival in early cervical carcinoma
- (2013) Jing Liu et al. GYNECOLOGIC ONCOLOGY
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- The prognostic value of tumor budding in invasive breast cancer
- (2013) Fenli Liang et al. PATHOLOGY RESEARCH AND PRACTICE
- Fibroblasts as architects of cancer pathogenesis
- (2012) Timothy Marsh et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Tumor-Stroma Ratio Is an Independent Predictor for Survival in Esophageal Squamous Cell Carcinoma
- (2012) kai Wang et al. Journal of Thoracic Oncology
- Tumor budding in colorectal carcinoma: time to take notice
- (2012) Bojana Mitrovic et al. MODERN PATHOLOGY
- Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
- (2011) Bin Gao et al. GASTROENTEROLOGY
- Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients
- (2010) Esther M. de Kruijf et al. BREAST CANCER RESEARCH AND TREATMENT
- The stromal part of adenocarcinomas of the oesophagus: Does it conceal targets for therapy?
- (2010) Ewout F.W. Courrech Staal et al. EUROPEAN JOURNAL OF CANCER
- Solitary cell infiltration is a novel indicator of poor prognosis and epithelial-mesenchymal transition in pancreatic cancer
- (2010) Yohei Masugi et al. HUMAN PATHOLOGY
- Multivariate Analysis of the Pathologic Features of Esophageal Squamous Cell Cancer: Tumor Budding Is a Significant Independent Prognostic Factor
- (2008) Masahiko Koike et al. ANNALS OF SURGICAL ONCOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started